Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Oncotarget|February 11, 2017
Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitroMauro Cives, Davide Quaresmini, Francesca Maria Rizzo, et al.
International Journal of Molecular Sciences|December 22, 2019
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma ProgressionFrancesco Mannavola, Stella D'Oronzo, Mauro Cives, et al.
BMC Cancer|February 13, 2016
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutationsFrancesca Maria Rizzo, Raffaele Palmirotta, Andrea Marzullo, et al.
Clinical and Experimental Medicine|January 19, 2024
Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experienceStella D'Oronzo, Mauro Cives, Eleonora Lauricella, et al.
Cancer Treatment Reviews|September 15, 2021
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectivesBarbara Mandriani, Eleonora Pelle', Gaetano Pezzicoli, et al.
Neuroendocrinology|July 30, 2019
A Phase II Study of Ibrutinib in Advanced Neuroendocrine NeoplasmsTaymeyah Al-Toubah, Michael J Schell, Mauro Cives, et al.
Cerebellum & Ataxias|January 7, 2021
Cerebellar ataxia and exercise intolerance in Erdheim-Chester diseaseEleonora Lauricella, Antonio d'Amati, Giuseppe Ingravallo, et al.
Oncotarget|June 5, 2018
SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksandRaffaele Palmirotta, Claudia Carella, Erica Silvestris, et al.
Critical Reviews in Oncology/Hematology|March 7, 2015
Erdheim-Chester disease: a systematic reviewMauro Cives, Valeria Simone, Francesca Maria Rizzo, et al.
BMC Cancer|October 16, 2015
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cellsValeria Simone, Sabino Ciavarella, Oronzo Brunetti, et al.
Pageof 8